logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Terence Fullerton

pfizer turkiye

12H指数
85论文数
723被引数
收录论文 19
发表时间
logo
Improvements in Patient-Reported Outcome Measures Through 64 Weeks’ Rimegepant Treatment for Migraine: Analysis of a Randomized Controlled Trial with Open-Label Extension通过64周盐酸瑞美地泮治疗偏头痛改善患者报告结局：一项随机对照试验及开放标签扩展分析
errJournal of Pain Research
IF2.5
err2026-09-23
err0
errOAAI
errRichard B Lipton; Dawn C Buse; Vincent T Martin; Dave Semel; Joseph C Cappelleri; Alexandra Thiry; Lucy Abraham; Terence Fullerton
err分享
err收藏
Efficacy and Safety of Oral Zavegepant in Migraine Prevention: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Migraine口服扎维杰潘坦预防偏头痛的疗效与安全性：一项针对慢性偏头痛患者的2/3期随机、双盲、安慰剂对照研究
errPain and Therapy
IF3.3
err2026-08-26
err0
errOAAI
errRobert J. Fountaine; Sergey Dubrovin; Linda Mosher; Jing Liu; Mohamed H. Shahin; Terence Fullerton
err分享
err收藏
Does rimegepant prevent migraine attacks in people who have not found other treatments taken by mouth (orally) to work well? A plain language summary of clinical study findings利美 gepant 是否能预防那些对口服（或经口）其他治疗药物效果不佳的偏头痛患者的偏头痛发作？临床研究结果的简明语言摘要
errPain Management
IF1.5
err2026-06-03
err0
PREAI
errPozo-Rosich, Patricia; Lopez, Jose Antonio Gien; Lisewski, Pawel; Aslan, Ayse Neslihan; Seehra, Harpreet; Thiry, Alexandra; Abraham, Lucy; Ramirez, Luz M.; Fountaine, Robert; Fullerton, Terence
err分享
err收藏
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial瑞美吉泮75 mg口腔崩解片用于成人慢性鼻窦炎急性治疗的疗效与安全性：一项多中心、随机、安慰剂对照、Ⅱ/Ⅲ期试验结果
errPLoS One
IF2.6
err2026-03-04
err0
PREAI
errFranjic, Daniel; Fountaine, Robert J.; Nalpas, Catherine; Goswami, Budhaditya; Fullerton, Terence
err分享
err收藏
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study日本人群偏头痛预防性治疗中使用瑞美吉泮的长期安全性与有效性：一项3期研究的开放标签扩展研究
errThe Journal of Headache and Pain
IF7.9
err2026-02-27
err0
errOAAI
errYasuhiko Matsumori; Shigekazu Kitamura; Toshimasa Yamamoto; Tomofumi Ishikawa; Yuko Hoshino; Hiroki Yoshimatsu; Alexandra Thiry; Akio Arakawa; Terence Fullerton; Fumihiko Sakai; Takao Takeshima
err分享
err收藏
Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo-controlled clinical trials
err
IF0
err2026-02-06
err0
errOAAI
errLarry Charleston IV MD, MSc; Cynthia E. Armand MD; Teshamae S. Monteith MD; Hope L. O'Brien MD, MBA; Chandra C. Abbott PhD; Glenn C. Pixton MS; Terence Fullerton
err分享
err收藏
A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention一项为期24周的4期、开放标签研究，旨在评估每日一次75 mg瑞美吉潘（rimegepant）用于发作性偏头痛预防的安全性和耐受性。
errThe Journal of Headache and Pain
IF7.9
err2025-12-09
err0
errOAAI
errJeremias Antinew; Robert J. Fountaine; Vittorio Loprinzo; Esther Straghan; Sergey Dubrovin; Patrizia DeBesi; Nick Vatakis; Terence Fullerton
err分享
err收藏
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial瑞美吉潘特用于不适合使用曲坦类药物的成人偏头痛急性治疗：一项随机、双盲、安慰剂对照的4期临床试验
errCephalalgia
IF4.6
err2025-11-18
err0
PREAI
errMessoud Ashina; Peter McAllister; Charly Gaul; Adolfo Leyva-Rendon; Luz M. Ramirez; Catherine Nalpas; Alexandra Thiry; Lucy Abraham; Robert J. Fountaine; Terence Fullerton
err分享
err收藏
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications一项4期、随机、双盲、安慰剂对照试验，评估瑞美 gepant 在预防有传统口服预防药物不耐受史成人发作性偏头痛方面的有效性和耐受性。
errCephalalgia
IF4.6
err2025-11-18
err0
errOAAI
errPatricia Pozo-Rosich; José Antonio Gien López; Pawel Lisewski; Ayşe Neslihan Aslan; Harpreet Seehra; Alexandra Thiry; Lucy Abraham; Luz M. Ramirez; Robert Fountaine; Terence Fullerton
err分享
err收藏
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial
errHEADACHE
IF4
err2025-11-01
err0
PREAI
errKitamura, Shigekazu; Matsumori, Yasuhiko; Yamamoto, Toshimasa; Ishikawa, Tomofumi; Hoshino, Yuko; Yoshimatsu, Hiroki; Thiry, Alexandra; Arakawa, Akio; Croop, Robert; Fullerton, Terence; Sakai, Fumihiko; Takeshima, Takao
err分享
err收藏
Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study
errCEPHALALGIA
IF4.6
err2024-08-30
err2
PREAI
errMullin, Kathleen; Croop, Robert; Mosher, Linda; Fullerton, Terence; Madonia, Jennifer; Lipton, Richard B.
err分享
err收藏
Pharmacokinetic and Pharmacodynamic Effects of a γ-Secretase Modulator, PF-06648671, on CSF Amyloid-β Peptides in Randomized Phase I Studies
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2019-09-11
err25
errOAAI
errAhn, Jae Eun; Carrieri, Charles; Dela Cruz, Fernando; Fullerton, Terence; Hajos-Korcsok, Eva; He, Ping; Kantaridis, Constantino; Leurent, Claire; Liu, Richann; Mancuso, Jessica; da Costa, Laure Mendes; Qiu, Ruolun
err分享
err收藏
A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil
errALZHEIMERS RESEARCH & THERAPY
IF7.6
err2018-04-05
err27
errOAAI
errFullerton, Terence; Binneman, Brendon; David, William; Delnomdedieu, Marielle; Kupiec, James; Lockwood, Peter; Mancuso, Jessica; Miceli, Jeffrey; Bell, Joanne
err分享
err收藏
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database
errALZHEIMERS & DEMENTIA
IF11.1
err2010-09-02
err100
PREAI
errIto, Kaori; Corrigan, Brian; Zhao, Qinying; French, Jonathan; Miller, Raymond; Soares, Holly; Katz, Elyse; Nicholas, Timothy; Billing, Bill; Anziano, Richard; Fullerton, Terence
err分享
err收藏
Disease progression meta-analysis model in Alzheimer's disease阿尔茨海默病疾病进展的meta分析模型
errALZHEIMERS & DEMENTIA
IF11.1
err2009-07-10
err154
PREAI
errIto, Kaori; Ahadieh, Sima; Corrigan, Brian; French, Jonathan; Fullerton, Terence; Tensfeldt, Thomas
err分享
err收藏
Population PK/PD evaluation of the QTcF interval-drug concentration relationship in healthy volunteers: A case study.
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2006-02-01
err2
PREAI
errRiley, SP; Sequeira, D; French, JL; Mancuso, JY; Benincosa, LJ; O'Sullivan, RL; Fullerton, T; Russell, T
err分享
err收藏
Characterization of P-glycoprotein inhibition at the blood brain barrier by ketoconazole and quinidine using the central pharmacodynamics of loperamide as an indicator of brain distribution.
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2005-02-01
err5
PREAI
errFullerton, T; Bednar, M; Raava, P; Legg, J; Hoelscher, D; Eckols, D; Gibbs, M
err分享
err收藏
Duration of human mu opiate receptor blockade following naltrexone: Measurement by 11C-carfentanil PET.
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2005-02-01
err3
PREAI
errBednarczyk, EM; Wack, D; Haka, M; Shang, Y; Hershey, L; O'Sullivan, R; Fullerton, T
err分享
err收藏
Pharmacokinetics (PK) and pharmacodynamics (PD) of orally (PO) administered midazolam (MDZ) in the presence and absence of intravenous (IV) flumazenil (F) in healthy volunteers.
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2003-02-16
err3
PREAI
errLawendy, NM; Holt, JL; Fullerton, T; Nafziger, AN; Snyder, PJ; Victory, J; Bertino, JS
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Richard B. Lipton
H 指数: 178 · 论文数: 1.8K
刘建军 封面图
刘建军 (Jianjun Liu)
H 指数: 131 · 论文数: 2.6K
P
Peter J. Snyder
H 指数: 89 · 论文数: 480
M
Messoud Ashina
H 指数: 89 · 论文数: 558
J
Joseph C. Cappelleri
H 指数: 67 · 论文数: 774
查看更多